Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs
PN Trewby, AV Reddy, CS Trewby, VJ Ashton, G Brennan and J Inglis
DOI: https://doi.org/10.7861/clinmedicine.2-6-527
Clin Med November 2002 PN Trewby
1Department of Medicine, Darlington Memorial Hospital, Darlington, Co Durham
MDAV Reddy
1Department of Medicine, Darlington Memorial Hospital, Darlington, Co Durham
MRCPCS Trewby
2General practitioner, Darlington
MRCPVJ Ashton
3School of Health and Social Care, University of Teeside
MScG Brennan
1Department of Medicine, Darlington Memorial Hospital, Darlington, Co Durham
RGN1J Inglis
1Department of Medicine, Darlington Memorial Hospital, Darlington, Co Durham
RGN1Article Information
vol. 2 no. 6 527-533
PubMed:
Published By:
Print ISSN:
Online ISSN:
History:
- Published online November 1, 2002.
Copyright & Usage:
© 2002 Royal College of Physicians
Author Information
Article usage
Article Tools
Are preventive drugs preventive enough? A study of patients' expectation of benefit from preventive drugs
PN Trewby, AV Reddy, CS Trewby, VJ Ashton, G Brennan, J Inglis
Clinical Medicine Nov 2002, 2 (6) 527-533; DOI: 10.7861/clinmedicine.2-6-527
Citation Manager Formats
Jump to section
Related Articles
- No related articles found.
Cited By...
- Communicating personalised statin therapy-effects as 10-year CVD-risk or CVD-free life-expectancy: does it improve decisional conflict? Three-armed, blinded, randomised controlled trial
- Exclusively plant, whole-food diet for polypharmacy due to persistent atrial fibrillation, ischaemic cardiomyopathy, hyperlipidaemia and hypertension in an octogenarian
- Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: a cross-sectional study of patient and primary care physician perspectives
- Patient preferences for cardiovascular preventive medication: a systematic review
- Labelling people as 'High Risk: A tyranny of eminence?
- The numbers needed to inform consent?
- Patients' Expectations of Screening and Preventive Treatments
- Dare to tell?
- Adding "value" to clinical practice guidelines
- Predictors of patients' preferences for treatments to prevent heart disease
- Of Struldbruggs, sugar, and gatekeepers: a tale of our times
- "Polypill" to fight cardiovascular disease: Patients before populations